Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Oregon Health & Science University (OHSU)

Status: Completed

Conditions: Parkinson's Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00912977

e5348

Details and patient eligibility

About

Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.

Full description

The main outcome measure of this study are measurements taken every half hour during an inpatient study visit. These measurements include standing on a forceplate for 1 minute while performing a mental task such as reciting the alphabet backwards. During this forceplate stance, a rater will visually score your movements. All participants must be eligible for another Parkinson's disease study at Oregon Health and Science University.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Parkinsons disease
• Older than 18

Exclusion criteria

• Must be participating in a Parkinsons disease study at Oregon Health & Science University

Trial design

10 participants in 3 patient groups

Group 1

Description:

Groups are defined by another study

Group 2

Description:

Groups are defined by another study

Group 3

Description:

Groups are defined by another study